| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec408b88895b27a0442fc068d611b89f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-035 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2009-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dddea80ba22a41147492e29003baaae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f58f0e7fe11b88c4d24835a34e56c339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621d9ea8240eeb1b09a6f79b06784632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ec9eedab4fa7ab1f2b7a3c0f27d44d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8742b68a7973568dd774b8167effd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc74113ead242b564a2bb17f641966cf |
| publicationDate |
2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2539765-C2 |
| titleOfInvention |
HIV VACCINE BASED ON MAXIMISED Gag AND Nef TARGETING ON DENDRITE CELLS |
| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to biotechnology. A method provides recovering and purifying a dendrite cell (DC) receptor specific antibody or its fragment to which a Gag antigen is attached. A Nef antigen is optionally attached to the DC-receptor specific antibody or its fragment, or to the Gag antigen. The Gag antigen is less sensitive to proteolytic degradation by eliminating one or more proteolytic sites. That is followed by contacting the DC-receptor specific antibody or its fragment to which the Gag antibody is attached to form an antibody-antigen complex, to an antigen-representing cell. The DC-receptor specific antibody or its fragment to which the Gag antibody is attached to form the antibody-antigen complex, to an antigen-representing cell is processed and presented for T-cell recognition. n EFFECT: what is presented is a method of antigen load of the antigen-representing cell. n 32 cl, 33 dwg |
| priorityDate |
2008-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |